Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Eicosanoids and asthma: an update

F C Thien1, E H Walters

  • 1Department of Respiratory Medicine, Alfred Hospital, Prahran, Vic, Australia.

Prostaglandins, Leukotrienes, and Essential Fatty Acids
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease burden, comorbidities and antecedents of chronic cough phenotypes in Australian adults.

Pulmonology·2023
Same author

Preclinical interstitial lung disease in relatives of familial pulmonary fibrosis patients.

Pulmonology·2022
Same author

Mould-sensitized adults have lower Th2 cytokines and a higher prevalence of asthma than those sensitized to other aeroallergens.

Allergy·2016
Same author

Prospective outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease presenting to hospital: a generalisable clinical audit.

Internal medicine journal·2015
Same author

An observational study of PM10 and hospital admissions for acute exacerbations of chronic respiratory disease in Tasmania, Australia 1992-2002.

BMJ open respiratory research·2015
Same author

Cardiovascular effects of methacholine-induced airway obstruction in man.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2014
Same journal

Cardiovascular safety profile of prostaglandin E and prostacyclin analogues: Clinical reports and ex vivo studies on human coronary arteries.

Prostaglandins, leukotrienes, and essential fatty acids·2026
Same journal

Specialized pro-resolving mediator (SPM)-enriched supplementation modulates inflammatory biomarkers in patients with symptomatic knee osteoarthritis: Blood plasma analysis from the GAUDI study.

Prostaglandins, leukotrienes, and essential fatty acids·2026
Same journal

Serum fatty acid distributions and prevalence of low omega-3 status in early pregnancy: A cross-sectional analysis of 26,389 samples from an omega-3 test-and-treat program.

Prostaglandins, leukotrienes, and essential fatty acids·2026
Same journal

Association of fish intake with systemic immune-inflammation index: Potential mediating role of n-3 polyunsaturated fatty acids.

Prostaglandins, leukotrienes, and essential fatty acids·2026
Same journal

A novel algae oil-based emulsion enhances chemotherapy outcome in human cancer models.

Prostaglandins, leukotrienes, and essential fatty acids·2026
Same journal

Human milk omega-3 PUFA and infant neurodevelopment: Evidence and insights from indian mothers.

Prostaglandins, leukotrienes, and essential fatty acids·2026
See all related articles

Eicosanoids, crucial inflammation mediators, play key roles in asthma. Understanding these roles, like cysteinyl LTs and PGE2, offers new therapeutic targets for this chronic inflammatory condition.

Area of Science:

  • Biochemistry
  • Immunology
  • Pharmacology

Background:

  • Eicosanoids are recognized as key mediators of inflammation.
  • Asthma is increasingly understood as an inflammatory condition.
  • Eicosanoids are implicated as pivotal mediators in asthma pathogenesis.

Purpose of the Study:

  • To review the role of eicosanoids in asthma.
  • To highlight specific eicosanoids involved in asthma pathophysiology.
  • To discuss the therapeutic potential of targeting eicosanoids in asthma treatment.

Main Methods:

  • Literature review of eicosanoid research in inflammation and asthma.
  • Analysis of clinical studies investigating eicosanoid involvement in asthma.
  • Synthesis of current understanding of eicosanoid pathways in asthma.

Related Experiment Videos

Main Results:

  • Cysteinyl leukotrienes (LTs) are important in causing bronchospasm and bronchial hyperresponsiveness.
  • Prostaglandin E2 (PGE2) modulates bronchospastic and inflammatory responses in asthma.
  • Other eicosanoids may have secondary roles, with variable individual contributions.

Conclusions:

  • Eicosanoids are significant mediators in asthma.
  • Targeting eicosanoid pathways presents promising therapeutic strategies for asthma.
  • Further research into individual eicosanoid contributions may refine asthma treatments.